Clin2
NCT07765498Likely a fitNot yet recruiting

Safety study of a new medicine in healthy volunteers

Healthy

Treatments studied

This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
123 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be in generally good health, confirmed by a medical check-up.
  • You must have a body mass index (BMI) between 18 and 32.
  • You must not have certain chronic heart, lung, liver, kidney, or mental health conditions.
  • You must not have had cancer in the past 5 years (except certain low-risk skin or cervical conditions), or be cancer-free for a certain period.
  • You must have no active or recent infections and be free of hepatitis B, C, or HIV.
  • You must be willing to use effective contraception as required.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07090785Recruiting· Phase 1
Healthy volunteer study of LY4088044

This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.

Los Alamitos, California
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07767487Not yet recruiting· Phase 1
Study of LY4226695 in healthy volunteers

This study tests a new medicine called LY4226695 in healthy people to see how safe it is and how the body handles it. It is an early-stage trial, and participating may help develop a new treatment option.

Anaheim, California
NCT07566338Recruiting· Phase 1
Safety Study of LY4302814 in Healthy Adults

This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.

Daytona Beach, Florida
NCT07707375Recruiting· Phase 1
A study of LY4268989 (MORF 057) in healthy people

This study tests a new experimental medicine called LY4268989 (MORF 057) in healthy volunteers. The goal is to see how safe it is and how the body processes it.

Daytona Beach, Florida

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.